Ingenito Gary
- SEC CIK
- 0001279473
No open-market purchases or sales filed in the past year.
Current role at each company
- CPRX Catalyst Pharmaceuticals, Inc.Chief Med. & Reg. Officeras of May 15, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ingenito Gary as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2021 (view filing) | Dec 7 | 1 day | Ingenito GaryChief Medical Officer | SSaleCommon stock, par value $0.001 per share | −3.61K | $6.99 | −$25.2K | −14.1%22.1K after | |
| Jun 23, 2022 (view filing) | Jun 21-22 | 2 days | Ingenito GaryChief Medical & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −150.0K | $6.60 | −$990.1K | −87.2%22.1K after | 2 lots |
| Sep 16, 2022 (view filing) | Sep 14 | 2 days | Ingenito GaryChief Medical & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −143.0K | $15.67 | −$2.24M | −86.6%22.1K after | 2 lots |
| Dec 8, 2022 (view filing) | Dec 6 | 2 days | Ingenito GaryChief Medical Officer | SSaleCommon stock, par value $0.001 per share | −5.92K | $16.85 | −$99.7K | −16.1%30.8K after | |
| Dec 8, 2023 (view filing) | Dec 6 | 2 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −50.0K | $14.02 | −$701.0K | −56.6%38.4K after | |
| Jun 7, 2024 (view filing) | Jun 5 | 2 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −80.0K | $16.16 | −$1.29M | −60.9%51.4K after | |
| Aug 13, 2024 (view filing) | Aug 9 | 4 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −100.0K | $18.04 | −$1.80M | −66.1%51.4K after | |
| Nov 22, 2024 (view filing) | Nov 20 | 2 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −38.0K | $21.20 | −$805.6K | −42.5%51.4K after | |
| Nov 29, 2024 (view filing) | Nov 27 | 2 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −12.0K | $22.72 | −$272.6K | −18.9%51.4K after | 2 lots |
| Mar 7, 2025 (view filing) | Mar 5-6 | 2 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −225.0K | $21.75 | −$4.89M | −76.6%68.9K after | 2 lots |
| May 15, 2025 (view filing) | May 13-14 | 2 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −244.0K | $23.67 | −$5.78M | −78.0%68.9K after | 2 lots |